DBV Technologies S.A. ( DBVT) - Key Metrics
DBVT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.59 | -$0.97 | -$0.97 |
| 2026Q1 | $0 | -$0.56 | -$0.57 | -$0.58 |
| 2025Q4 | $0 | -$0.59 | -$0.46 | -$0.46 |
| 2025Q3 | $0 | -$0.34 | -$0.34 | -$0.34 |
| 2025Q2 | $0 | -$0.44 | -$0.35 | -$0.35 |
DBVT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.38 |
| 2026Q1 | 0% | -9.50 |
| 2025Q4 | 0% | -7.99 |
| 2025Q3 | 0% | -7.29 |
| 2025Q2 | 0% | -5.19 |
DBVT
Price: $9.03
52 week price:
Earnings Per Share: -3.50 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 78800
Ebitda: -157.7 millionMarket Capitalization: 252.4 million